Zoetis Inc.(ZTS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #223 of 2,879 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ZTS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Zoetis Inc. (ZTS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ZTS at 72.6/100 on a 32-signal composite quality model, placing it at rank #223 of 2,879 stocks — the top 10% of the AI-ranked universe. ZTS scores in the top quartile across balance sheet strength (95.1), profitability (89.7), revenue scale (86.1). Areas of concern include institutional flow (9.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Zoetis Inc. reports quarterly revenue of $2.3B, net income of $601.0M, an operating margin of 33.5%. Top institutional holders of ZTS by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ZTS trades on the NYSE exchange and files with the SEC under CIK 1555280. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Zoetis Inc. directly from SEC EDGAR. Zoetis Inc.'s 13F Pro composite quality score has ranged between 8 and 81 since 2021, currently 72.6 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$2.3B
Net Income
Q1 2026
$601.0M
Free Cash Flow
Q1 2026
$291.0M
Operating Margin
Q1 2026
33.5%
D/E Ratio
Q1 2026
2.80
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+2.3% YoYNet Income
+7.5% YoYEPS (Diluted)
+10.1% YoYTotal Assets
+8.6% YoYTotal Debt
+37.6% YoYOp. Cash Flow
-1.7% YoY| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $9.47B +2.3% | $9.26B +14.6% | $8.08B +21.0% | $6.67B +6.6% | $6.26B +7.5% | $5.83B |
| Net Income | $2.67B +7.5% | $2.49B +17.6% | $2.11B +29.1% | $1.64B +9.2% | $1.50B +5.0% | $1.43B |
| EPS (Diluted) | $6.02 +10.1% | $5.47 +21.8% | $4.49 +31.3% | $3.42 +10.0% | $3.11 +6.1% | $2.93 |
| Total Assets | $15.47B +8.6% | $14.24B -4.6% | $14.93B +9.7% | $13.61B +17.9% | $11.54B +7.1% | $10.78B |
| Total Debt | $9.04B +37.6% | $6.57B -16.9% | $7.90B +9.8% | $7.20B +3.6% | $6.95B +7.7% | $6.45B |
| Operating Cash Flow | $2.90B -1.7% | $2.95B +54.4% | $1.91B -10.1% | $2.13B +18.4% | $1.79B +0.3% | $1.79B |
Get alerted when ZTS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Zoetis Inc. including:
Top Institutional Holders of ZTS
BlackRock, Inc.
$4.2B35,584,312 shVANGUARD CAPITAL MANAGEMENT LLC
$3.1B26,072,846 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.8B23,967,400 shSTATE STREET CORP
$2.3B19,324,401 shSTATE FARM MUTUAL AUTOMOBILE INSURANCE CO
$1.9B15,892,903 shMORGAN STANLEY
$1.7B14,145,735 shGEODE CAPITAL MANAGEMENT, LLC
$1.3B11,349,248 shWELLINGTON MANAGEMENT GROUP LLP
$1.2B10,150,096 shNORDEA INVESTMENT MANAGEMENT AB
$679.8M5,865,111 shNORTHERN TRUST CORP
$655.6M5,546,057 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $4.2B | 35,584,312 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.1B | 26,072,846 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.8B | 23,967,400 |
| STATE STREET CORP | $2.3B | 19,324,401 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.9B | 15,892,903 |
| MORGAN STANLEY | $1.7B | 14,145,735 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.3B | 11,349,248 |
| WELLINGTON MANAGEMENT GROUP LLP | $1.2B | 10,150,096 |
| NORDEA INVESTMENT MANAGEMENT AB | $679.8M | 5,865,111 |
| NORTHERN TRUST CORP | $655.6M | 5,546,057 |
More Healthcare Companies
View all Healthcare →Put ZTS on your watchlist
Track score changes the day Zoetis Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ZTS a good stock to buy?
13F Pro's AI-powered analysis of Zoetis Inc. (ZTS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ZTS are available on the ZTS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ZTS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ZTS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Zoetis Inc.'s investment landscape.